Industries
We champion the bold to achieve the extraordinary
Our industry focuses span the pharmaceutical ecosystem. From enterprise pharmaceutical companies to emerging biotechnology firms, we provide tailored pharmaceutical pricing and market access intelligence that drives results across diverse industry sectors.
Empowering Founders with Strategic Guidance and Hands-On Support
We partner with startup and small business founders, from the initial idea stage to approximately $3M in annual revenue. Blending the roles of business coaches and consultants, we provide guidance where possible and step in when needed. This unique mix makes us more effective than traditional coaches and more affordable than most consultants—we’re here to teach, not just execute.
Our clients are visionary innovators focused on product, strategy, and customers. We enhance their strengths with structured business guidance, helping them make data-driven decisions and scale efficiently.
Enterprise, mid-market & emerging pharmaceutical
Transform global pricing complexity with comprehensive intelligence and strategic guidance.
What we deliver
- Portfolio optimisation and competitive benchmarking across global markets
- Global pricing strategies with comprehensive IRP risk management
- Launch excellence support with market access pathway guidance
- Post-launch revenue optimisation and lifecycle management strategies
How we help
- Navigate complex stakeholder landscapes with confidence
- Accelerate decision-making with real-time market intelligence
- Reduce pricing risks through comprehensive scenario planning
- Optimise commercial performance across diverse therapeutic areas
Typical engagements
- Global launch strategy development and execution
- Portfolio prioritisation and asset valuation analysis
- Competitive intelligence and market positioning strategies
- Regulatory compliance and policy impact assessment
Biotechnology
Early-stage valuation, clinical trial pricing, and market entry strategies for innovative therapies.
What we deliver
- Early-stage valuation with comprehensive market analysis
- Clinical trial pricing strategies and cost-effectiveness modelling
- Market entry strategies tailored to novel therapeutic approaches
- Investor presentation support with robust market intelligence
How we help
- Validate commercial potential during development phases
- Prepare compelling value propositions for payers and investors
- Navigate regulatory pathways with confidence
- Optimise resource allocation across development programmes
Typical engagements
- Pre-clinical asset valuation and market opportunity analysis
- Phase II/III pricing strategy development
- Regulatory submission support and evidence generation planning
- Partnership and licensing deal support with market intelligence
Clinical research organisations
Comprehensive market intelligence supporting drug development and commercialisation services.
What we deliver
- Market access consulting services for sponsor companies
- Pricing intelligence supporting protocol development
- Competitive landscape analysis for development programmes
- Health economics and outcomes research support
How we help
- Enhance service offerings with proprietary market intelligence
- Support sponsor companies with expert market access guidance
- Reduce development risks through comprehensive market analysis
- Differentiate service offerings with advanced analytics capabilities
Typical engagements
- Protocol optimisation with market access considerations
- Competitive intelligence services for sponsor companies
- Competitive intelligence services for sponsor companies
- Market access strategy development for late-stage assets
Financial institutions
Investment analysis and market intelligence for pharmaceutical sector investments.
What we deliver
- Investment thesis validation with comprehensive market analysis
- Competitive landscape assessment for portfolio companies
- Market opportunity quantification and risk assessment
- Due diligence support with proprietary intelligence
How we help
- Due diligence support with proprietary intelligence
- Support portfolio companies with strategic pricing guidance
- Identify market opportunities and competitive threats
- Enhance investment returns through strategic market positioning
Typical engagements
- Pre-investment due diligence and market validation
- Portfolio company strategic support and market guidance
- Competitive intelligence for investment decision-making
- Market opportunity assessment for new therapeutic areas
Professional services and consulting
Data partnerships and integrated solutions for consulting firms and service providers.
What we deliver
- White-label market intelligence solutions
- API integration for seamless data access
- Co-branded research and analysis capabilities
- Strategic partnership opportunities for enhanced service delivery
How we help
- Enhance service offerings with proprietary pharmaceutical intelligence
- Differentiate capabilities with unique market access expertise
- Expand addressable market through comprehensive data solutions
- Build strategic partnerships for mutual client value creation
Typical engagements
- Strategic partnership development and implementation
- White-label solution development and deployment
- Joint client engagement and service delivery
- Market intelligence integration for enhanced consulting services
GPI was able to provide base-case and worst-case forecasts, as well as surrounding strategy for supporting indication optimisation to ensure maximum asset revenue.
